Klor-con m10 and Acyclovir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Klor-con m10 (potassium chloride) and Acyclovir (acyclovir). Common drug interactions include deep vein thrombosis among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Klor-con m10 and Acyclovir. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Klor-con m10?

Klor-con m10 has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 1,379 Klor-con m10 users. Check the latest studies of Klor-con m10.

What is Acyclovir?

Acyclovir has active ingredients of acyclovir. It is often used in herpes simplex. eHealthMe is studying from 54,961 Acyclovir users. Check the latest studies of Acyclovir.

On Jul, 07, 2026

22 people who take Klor-con m10 and Acyclovir together, and have interactions are studied.

Klor-con m10 and Acyclovir drug interactions.

What are the common drug interactions of Klor-Con M10 and Acyclovir, by gender? *:

female:

Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Hospitalisation
Pain
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Disease progression
Drug ineffective
Ejection fraction decreased (systolic heart failure)
Full blood count decreased
Malaise (a feeling of general discomfort or uneasiness)
Nausea (feeling of having an urge to vomit)

male:

Diarrhoea
Neutropenia (an abnormally low number of neutrophils)
Loss of consciousness
Neuropathy peripheral (surface nerve damage)
Platelet count decreased
Pyrexia (fever)
Respiratory tract infection
Thrombocytopenia (decrease of platelets in blood)
White blood cell count decreased
Death

What are the common drug interactions of Klor-Con M10 and Acyclovir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Nausea (feeling of having an urge to vomit)
Neuropathy peripheral (surface nerve damage)
Vomiting

60+:

Diarrhoea
Neutropenia (an abnormally low number of neutrophils)
Confusional state
Constipation
Disease progression
Drug ineffective
Ejection fraction decreased (systolic heart failure)
Fatigue (feeling of tiredness)
Loss of consciousness
Neck pain

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 14 people, 63.64%
Pain: 3 people, 13.64%
Primary Myelofibrosis (primary disorder of the bone marrow): 2 people, 9.09%
Immunodeficiency Common Variable: 2 people, 9.09%
Cough: 2 people, 9.09%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Klor-con m10 and Acyclovir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously